A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/30 (2006.01) A61K 31/505 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2345353
New methods for the treatment of cancer are provided. Null IGF(IGF variants with reduced receptor binding) is administered to subjects having cancer, thereby alleviating the symptoms of the cancer.
Cette invention a trait à de nouvelles méthodes de thérapie anticancéreuse, dans le cadre desquelles on administre de l'IGF inactif (variants d'IGF capacité de fixation de récepteurs réduite) à des sujets atteints d'un cancer, ce qui a pour effet de soulager les symptômes du cancer.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Celtrix Pharmaceuticals Inc.
LandOfFree
Null igf for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Null igf for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Null igf for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1838370